Search Results 861-870 of 17365 for Embolism

  1. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    ... embolism [PE]) within 6 months before first dose. GI disorders including those associated with a high risk of perforation or fistula formation: The patient ...

  2. Publications - Matthew M. Melin, M.D. - Mayo Clinic

    Atrial Fibrillation related embolic event resulting in occlusion of the internal carotid artery; case report Journal for Vascular Ultrasound. 2009; 33:145 ...

  3. A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms - Mayo Clinic

    Known history of a major cardiovascular or cerebrovascular event within 24 months, pulmonary arterial hypertension, pulmonary embolism within 6 months of ...

  4. Mayo Clinic Q&A - COVID and cardiac complications - Dr. Lesl...

    Dr. Leslie Cooper 00:18. This is a virus that affects the lining of the blood vessels. When they are infected they become dysfunctional, and blood clots ...

  5. Advancing science through medical education - Mayo Clinic

    Within Pulmonary and Critical Care Medicine at Mayo Clinic, educators and developing education scientists are honing their craft — leading to groundbreaking ...

  6. Marfan syndrome - Doctors and departments - Mayo Clinic

    ... embolism. Show more areas of focus for Sam Farres, M.D.. Research. Mayo Clinic doctors and researchers are studying a variety of diagnostic and treatment ...

  7. Researchers identify factors that impact central nervous system injury and repair - Mayo Clinic

    Mayo Clinic neuroregeneration and neurorehabilitation researchers continue to examine cellular and molecular mechanisms contributing to injury and repair ...

  8. Taking a Closer Look at Menopausal Hormone Therapy and Cognitive Health - Mayo Clinic News Network

    Frailty linked to poor outcomes in pulmonary embolism patients. Discovery Science. More Mayo neuroscience: Brain cells 'crosstalk' and cancer growth ...

  9. A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical Treatment CTEPH - Mayo Clinic

    A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical ...

  10. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label - Mayo Clinic

    Significant thrombotic or embolic events within 3 months prior to randomization (significant thrombotic or embolic events include but are not limited to stroke ...